key: cord-0957754-vkdl44hp
authors: Meecham, Lewis; Al Shakarchi, Julien; Rahman, Habib P; Nyamekye, Isaac K
title: Surgery during the COVID-19 pandemic
date: 2020-11-05
journal: Lancet
DOI: 10.1016/s0140-6736(20)32277-7
sha: 784d3a3a8720c1e8ad68b3dadab809b9c5291455
doc_id: 957754
cord_uid: vkdl44hp

nan

However, no information is provided on the protocols for venous thromboembolism prophylaxis that must have been used for these patients. Detailed information on the perioperative and postoperative regimen used (eg, drugs, dosage, and duration) for venous thromboembolism prophylaxis would provide a valuable perspective on the low pulmonary embolism rates reported in this study. As health services worldwide begin to slowly re-establish elective surgical activity, any evidence that contributes to guidance for perioperative and postoperative venous thromboembolism prophylaxis would be of great value. Surgeons are in need of data in this patient group, and the COVIDSurg Collaborative could have provided such evidence.

We declare no competing interests.

Crown Copyright © 2020 Published by Elsevier Ltd. All rights reserved.

Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study

Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia

Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study

Venous thromboembolism and heparin use in COVID-19 patients: juggling between pragmatic choices, suggestions of medical societies